Clinical Trial Results:
            A phase II, randomized, double-blind, placebo controlled, multi-center study to evaluate the effects of LCI699 on cortisol in patients with hypertension.
    
|     Summary | |
|     EudraCT number | 2008-007337-49 | 
|     Trial protocol | IS | 
|     Global completion date | 
                                    12 Aug 2009
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v2(current) | 
|     This version publication date | 
                                    29 Sep 2021
                             | 
|     First version publication date | 
                                    17 May 2018
                             | 
|     Other versions | v1 | 
|     Version creation reason | 
 | 
|     Summary report(s) | CLCI699A2215 NVS CTR full results | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
